113 related articles for article (PubMed ID: 9093005)
1. Low-dose brain natriuretic peptide infusion in normal men and the influence of endopeptidase inhibition.
Florkowski CM; Richards AM; Espiner EA; Yandle TG; Sybertz E; Frampton CM
Clin Sci (Lond); 1997 Mar; 92(3):255-60. PubMed ID: 9093005
[TBL] [Abstract][Full Text] [Related]
2. Neutral endopeptidase inhibition: augmented atrial and brain natriuretic peptide, haemodynamic and natriuretic responses in ovine heart failure.
Rademaker MT; Charles CJ; Espiner EA; Nicholls MG; Richards AM; Kosoglou T
Clin Sci (Lond); 1996 Sep; 91(3):283-91. PubMed ID: 8869410
[TBL] [Abstract][Full Text] [Related]
3. Bioactivity and metabolism of C-type natriuretic peptide in normal man.
Hunt PJ; Richards AM; Espiner EA; Nicholls MG; Yandle TG
J Clin Endocrinol Metab; 1994 Jun; 78(6):1428-35. PubMed ID: 8200946
[TBL] [Abstract][Full Text] [Related]
4. Renal, endocrine, and hemodynamic effects of human brain natriuretic peptide in normal man.
Holmes SJ; Espiner EA; Richards AM; Yandle TG; Frampton C
J Clin Endocrinol Metab; 1993 Jan; 76(1):91-6. PubMed ID: 8380606
[TBL] [Abstract][Full Text] [Related]
5. Differing biological effects of equimolar atrial and brain natriuretic peptide infusions in normal man.
Hunt PJ; Espiner EA; Nicholls MG; Richards AM; Yandle TG
J Clin Endocrinol Metab; 1996 Nov; 81(11):3871-6. PubMed ID: 8923831
[TBL] [Abstract][Full Text] [Related]
6. Brain natriuretic peptide and neutral endopeptidase inhibition in left ventricular impairment.
Lainchbury JG; Richards AM; Nicholls MG; Espiner EA; Yandle TG
J Clin Endocrinol Metab; 1999 Feb; 84(2):723-9. PubMed ID: 10022444
[TBL] [Abstract][Full Text] [Related]
7. Urinary endothelin-1 excretion is enhanced by low-dose infusion of brain natriuretic peptide in normal humans.
De Feo ML; La Villa G; Lazzeri C; Tosti-Guerra C; Becorpi A; Pupilli C; Mannelli M
Hypertension; 1997 Jan; 29(1 Pt 1):70-4. PubMed ID: 9039083
[TBL] [Abstract][Full Text] [Related]
8. Acute inhibition of endopeptidase 24.11 in essential hypertension: SCH 34826 enhances atrial natriuretic peptide and natriuresis without lowering blood pressure.
Richards AM; Crozier IG; Espiner EA; Ikram H; Yandle TG; Kosoglou T; Rallings M; Frampton C
J Cardiovasc Pharmacol; 1992; 20(5):735-41. PubMed ID: 1280735
[TBL] [Abstract][Full Text] [Related]
9. Interactions of atrial and brain natriuretic peptides at pathophysiological levels in normal men.
Hunt PJ; Espiner EA; Richards AM; Yandle TG; Frampton C; Nicholls MG
Am J Physiol; 1995 Dec; 269(6 Pt 2):R1397-403. PubMed ID: 8594942
[TBL] [Abstract][Full Text] [Related]
10. Effects of physiological increments in human alpha-atrial natriuretic peptide and human brain natriuretic peptide in normal male subjects.
Cheung BM; Dickerson JE; Ashby MJ; Brown MJ; Brown J
Clin Sci (Lond); 1994 Jun; 86(6):723-30. PubMed ID: 8062508
[TBL] [Abstract][Full Text] [Related]
11. Hemodynamic and hormonal effects of neutral endopeptidase inhibitor SCH 39370 in sheep.
Charles CJ; Espiner EA; Cameron VA; Richards AM; Yandle TG; Sybertz EJ
Hypertension; 1991 May; 17(5):643-51. PubMed ID: 1850715
[TBL] [Abstract][Full Text] [Related]
12. Plasma brain natriuretic peptide and endopeptidase 24.11 inhibition in hypertension.
Richards AM; Crozier IG; Espiner EA; Yandle TG; Nicholls MG
Hypertension; 1993 Aug; 22(2):231-6. PubMed ID: 8340158
[TBL] [Abstract][Full Text] [Related]
13. Clearance receptors and endopeptidase 24.11: equal role in natriuretic peptide metabolism in conscious sheep.
Charles CJ; Espiner EA; Nicholls MG; Richards AM; Yandle TG; Protter A; Kosoglou T
Am J Physiol; 1996 Aug; 271(2 Pt 2):R373-80. PubMed ID: 8770137
[TBL] [Abstract][Full Text] [Related]
14. Acute effects of physiological increments of brain natriuretic peptide in humans.
La Villa G; Stefani L; Lazzeri C; Zurli C; Guerra CT; Barletta G; Bandinelli R; Strazzulla G; Franchi F
Hypertension; 1995 Oct; 26(4):628-33. PubMed ID: 7558223
[TBL] [Abstract][Full Text] [Related]
15. Renal, endocrine, and hemodynamic interactions of atrial and brain natriuretic peptides in normal men.
Florkowski CM; Richards AM; Espiner EA; Yandle TG; Frampton C
Am J Physiol; 1994 Apr; 266(4 Pt 2):R1244-50. PubMed ID: 8184968
[TBL] [Abstract][Full Text] [Related]
16. Acute and chronic neutral endopeptidase inhibition in rats with aortocaval shunt.
Willenbrock R; Scheuermann M; Höhnel K; Luft FC; Dietz R
Hypertension; 1996 Jun; 27(6):1259-66. PubMed ID: 8641733
[TBL] [Abstract][Full Text] [Related]
17. Combined endopeptidase inhibition and adrenomedullin in sheep with experimental heart failure.
Rademaker MT; Charles CJ; Cooper GJ; Coy DH; Espiner EA; Lewis LK; Nicholls MG; Richards AM
Hypertension; 2002 Jan; 39(1):93-8. PubMed ID: 11799085
[TBL] [Abstract][Full Text] [Related]
18. Clearance receptors and endopeptidase: equal role in natriuretic peptide metabolism in heart failure.
Rademaker MT; Charles CJ; Kosoglou T; Protter AA; Espiner EA; Nicholls MG; Richards AM
Am J Physiol; 1997 Nov; 273(5):H2372-9. PubMed ID: 9374774
[TBL] [Abstract][Full Text] [Related]
19. Comparative bioactivity of atrial and brain natriuretic peptides in an ovine model of heart failure.
Rademaker MT; Charles CJ; Espiner EA; Frampton CM; Nicholls MG; Richards AM
Clin Sci (Lond); 1997 Feb; 92(2):159-65. PubMed ID: 9059317
[TBL] [Abstract][Full Text] [Related]
20. Brain natriuretic peptide: natriuretic and endocrine effects in essential hypertension.
Richards AM; Crozier IG; Holmes SJ; Espiner EA; Yandle TG; Frampton C
J Hypertens; 1993 Feb; 11(2):163-70. PubMed ID: 8385176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
